References
- Forcier M, Musacchio N. An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention. Dermatol Ther. 2010;23(5):458–476.
- Dall’Oglio F, D’Amico V, Nasca MR, et al. Treatment of cutaneous warts. Am J Clin Dermatol. 2012;13(2):73–96.
- Massad LS, Xie X, Darragh T, et al. Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection. Obstet Gynecol. 2011;118(4):831–839.
- Salem A, Nofal A, Hosny D. Treatment of common and plane warts in children with topical viable bacillus Calmette-Guerin. Pediatr Dermatol. 2013;30(1):60–63.
- Eassa BI, Abou‐Bakr AA, El‐Khalawany MA. Intradermal injection of PPD as a novel approach of immunotherapy in anogenital warts in pregnant women. Dermatol Ther. 2011;24(1):137–143.
- Khozeimeh F, Jabbari Azad F, Mahboubi Oskouei Y, et al. Intralesional immunotherapy compared to cryotherapy in the treatment of warts. Int J Dermatol. 2017;56(4):474–478.
- Ahn CS, Huang WW. Imiquimod in the treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2014;15(5):387–399.
- Kansal NK. Immunotherapy of anogenital warts with measles, mumps, and rubella vaccine. Dermatol Ther. 2020;33(6):e13987.
- Majid I, Imran S. Immunotherapy with intralesional Candida albicans antigen in resistant or recurrent warts: a study. Indian J Dermatol. 2013;58(5):360.
- Horn TD, Johnson SM, Helm RM, et al. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol. 2005;141(5):589–594.
- Sharquie KE, Al-Rawi JR, Al-Nuaimy AA, et al. Bacille Calmette-Guerin immunotherapy of viral warts. Saudi Med J. 2008;29(4):589–593.
- Podder I, Bhattacharya S, Mishra V, et al. Immunotherapy in viral warts with intradermal Bacillus Calmette–Guerin vaccine versus intradermal tuberculin purified protein derivative: a double-blind, randomized controlled trial comparing effectiveness and safety in a tertiary care center in Eastern India. Indian J Dermatol Venereol Leprol. 2017;83(3):411.
- Opaneye AA. The cellular immune system in female patients with or without genital warts: a study of peripheral white blood cell components. Int J STD AIDS. 1999;10(12):815–816.
- Valiathan R, Ashman M, Asthana D. Effects of ageing on the immune system: infants to elderly. Scand J Immunol. 2016;83(4):255–266.
- Rao AG, Haqqani R. Study of BCG immunotherapy in the management of multiple, extensive non-genital cutaneous common warts. Indian Dermatol Online J. 2020;11(5):784–788.
- Jagati A, Agarwal S, Parmar KS, et al. A prospective interventional study of 50 patients to assess the effectiveness and safety of intralesional reconstituted bacille calmette guerin immunotherapy in treatment of warts. Int J Adv Res. 2017;3:37–41.
- Nofal A, Nofal E. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatol Venereol. 2010;24(10):1166–1170.
- Signore RJ. Candida albicans intralesional injection immunotherapy of warts. Cutis. 2002;70(3):185–192.
- Kim D-Y, Park H-s, Cho S, et al. Factors to determining treatment response cryotherapy for foot warts. Dermatology. 2014;229:310–315.
- Berth-Jones J, Hutchinson PE. Modern treatment of warts: cure rates at 3 and 6 months. Br J Dermatol. 1992;127(3):262–265.
- Ahmed I, Agarwal S, Ilchyshyn A, et al. Liquid nitrogen cryotherapy of common warts: cryo-spray vs. cotton wool bud. Br J Dermatol. 2001;144(5):1006–1009.